Abstract
The brain’s serotonin (5-HT) system plays an important role in the control of normal and pathological behavior. 5-HT2A receptors are widely implicated in the regulation of normal brain functions and in the pathogenesis of mental disorders, especially schizophrenia and depression. In this work, we studied the involvement of 5-HT2A receptors in the action of the brain-derived neurotrophic factor (BDNF) and the glial cell line-derived neurotrophic factor (GDNF). It was found that an acute intracerebroventricular BDNF injection caused a considerable increase in the functional activity of 5-HT2A receptors in ASC mice genetically predisposed to depression-like behavior. Moreover, as a result of the administration of BDNF, the expression of the 5-HT2A receptor gene increased in the hippocampus, decreased in the frontal cortex, and did not change in the midbrain. In contrast, GDNF administration did not affect the functional activity of 5-HT2A receptors, but increased the expression of the 5-HT2A receptor gene in the frontal cortex, but not in the hippocampus or the midbrain. Thus, the central administration of BDNF and GDNF was shown to affect the functional activity of 5-HT2A receptors and the expression of their genes. These results indicate that 5-HT2A receptors can be involved in the mechanisms of BDNF and GDNF action.
Similar content being viewed by others
Abbreviations
- 5-HT:
-
serotonin
- 5-HT2A :
-
receptor, subtype 2A serotonin receptor
- BDNF:
-
brain-derived neurotrophic factor
- GDNF:
-
glial cell line-derived neurotrophic factor
- FGFR:
-
fibroblast growth factor receptor
- Polr2a :
-
DNA-directed RNA polymerase II gene
- Gapdh :
-
glyceraldehyde-3-phosphate dehydrogenase gene
- RT:
-
reverse transcription
- PCR:
-
polymerase chain reaction
- FST:
-
forced swim test
References
Popova N.K., Naumenko E.V., Kolpakov V.G. 1978. Serotonin i povedenie (Serotonin and Behavior), Novosibirsk: Nauka.
Lucki I. 1998. The spectrum of behaviors influenced by serotonin. Biol. Psychiatry. 44, 151–162.
Hannon J., Hoyer D. 2008. Molecular biology of 5-HT receptors. Behav. Brain. Res. 195, 198–213.
Dean B. 2003. The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. J. Neurochem. 85, 1–13.
Mintun M.A., Sheline Y.I., Moerlein S.M., Vlassenko A.G., Huang Y., Snyder A.Z. 2004. Decreased hippocampal 5-HT2A receptorbinding in major depressive disorder: In vivo measurement with [18F]altanserin positron emission tomography. Biol. Psychiatry. 55, 217–224.
Alex K.D., Pehek E.A. 2007. Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission. Pharmacol. Ther. 113, 296–320.
Deltheil T., Guiard B.P., Cerdan J., David D.J., Tanaka K.F., Reperant C., Guilloux J.P., Coudore F., Hen R., Gardier A.M. 2008. Behavioral and serotonergic consequences of decreasing or increasing hippocampus brain-derived neurotrophic factor protein levels in mice. Neuropharmacology. 55, 1006–1014.
Duman R.S. 2009. Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin. Neurosci. 11, 239–255.
Rangasamy S.B., Soderstrom K., Bakay R.A., Kordower J.H. 2010. Neurotrophic factor therapy for Parkinson’s disease. Prog. Brain. Res. 184, 237–264.
Hoshaw B.A., Malberg J.E., Lucki I. 2005. Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects. Brain Res. 1037, 204–208.
Hisaoka K., Nishida A., Takebayashi M., Koda T., Yamawaki S., Nakata Y. 2004. Serotonin increases glial cell line-derived neurotrophic factor release in rat C6 glioblastoma cells. Brain Res. 1002, 167–170.
Tsuchioka M., Takebayashi M., Hisaoka K., Maeda N., Nakata Y. 2008. Serotonin (5-HT) induces glial cell line-derived neurotrophic factor (GDNF) mRNA expression via the transactivation of fibroblast growth factor receptor 2 (FGFR2) in rat C6 glioma cells. J. Neurochem. 106, 244–257.
Zhang X., Zhang Z., Xie C., Xi G., Zhou H., Zhang Y., Sha W. 2008. Effect of treatment on serum glial cell line-derived neurotrophic factor in depressed patients. Prog. Neuropsychopharmacol. Biol. Psychiatry. 32, 886–890.
Diniz B.S., Teixeira A.L., Miranda A.S., Talib L.L., Gattaz W.F., Forlenza O.V. 2012. Circulating glial-derived neurotrophic factor is reduced in late-life depression. J. Psychiatr. Res. 46, 135–139.
Vaidya V.A., Marek G.J., Aghajanian G.K., Duman R.S. 1997. 5-HT2A receptor-mediated regulation of brain-derived neurotrophic factor mRNA in the hippocampus and the neocortex. J. Neurosci. 17, 2785–2795.
Meller R., Babity J.M., Grahame-Smith D.G. 2002. 5-HT2A receptor activation leads to increased BDNF mRNA expression in C6 glioma cells. Neuromol. Med. 1, 197–205.
Tan Q.R., Wang X.Z., Wang C.Y., Liu X.J., Chen Y.C., Wang H.H., Zhang R.G., Zhen X.C., Tong Y., Zhang Z.J. 2007. Differential effects of classical and atypical antipsychotic drugs on rotenone-induced neurotoxicity in PC12 cells. Eur. Neuropsychopharmacol. 17, 768–773.
Kulikov A.V., Bazovkina D.V., Kondaurova E.M., Popova N.K. 2008. Genetic structure of hereditary catalepsy in mice. Genes Brain Behav. 7, 506–512.
Slotnick B.M., Leonard C.M. 1975. A Stereotaxic Atlas of the Albino Mouse Forebrain. Rockville, MD: U.S. Dept. Health, Education and Welfare.
Green A.R., Heal D.J. 1985. The effects of drugs on serotonin-mediated behavioural models. In: Neuropharmacology of Serotonin. Ed. Green A.R. Oxford: Oxford Univ. Press, pp. 326–365.
Naumenko V.S., Kulikov A.V. 2006. Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol. Biol. (Moscow). 40, 30–36.
Moisan M.-P., Courvoisier H., Bihoreau M.-T., Gauguier D., Hendley E.D., Lathrop M., James M.R. Mormede P. 1996. A major quantitative trait locus influences hyperactivity in the WKHA rat. Nature Genet. 14, 471–473.
Siuciak J.A., Lewis D.R. Wiegand S.J., and Lindsay R.M. 1997. Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav. 56, 131–137.
Shirayama Y., Chen A.C., Nakagawa S., Russell D.S., Duman R.S. 2002. Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression. J. Neurosci. 22, 3251–3261.
Zanardi R., Artigas F., Moresco R., Colombo C., Messa C., Gobbo C., Smeraldi E., Fazio F. 2001. Increased 5-hydroxytryptamine-2 receptor binding in the frontal cortex of depressed patients responding to paroxetine treatment: a positron emission tomography scan study. J. Clin. Psychopharmacol. 21, 53–58.
Bach H., Arango V. 2012. Neuroanatomy of serotonergic abnormalities in suicide. In: The Neurobiological Basis of Suicide. Ed. Dwivedi Y. Boca Raton, FL: CRC Press, pp. 11–29.
Nemeroff C.B. 2005. Use of atypical antipsychotics in refractory depression and anxiety. J. Clin. Psychiatry. 66, 13–21.
Semenova A.A., Bazovkina D.V., Tsybko A.S., Naumenko V.S., Popova N.K. 2013. Effect of GDNF on the behavior of ASC mice with high hereditary predisposition to catalepsy. Zh. Vyssh. Nerv. Deyat. 63, 495–501.
Pascual A., Hidalgo-Figueroa M., Gómez-Díaz R., López-Barneo J. 2011. GDNF and protection of adult central catecholaminergic neurons. J. Mol. Endocrinol. 46, 83–92.
Klein A.B., Santini M.A., Aznar S., Knudsen G.M., Rios M. 2010. Changes in 5-HT2A-mediated behavior and 5-HT2A- and 5-HT1A receptor binding and expression in conditional brain-derived neurotrophic factor knockout mice. Neuroscience. 169, 1007–1016.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Tsybko, T.V. Il’chibaeva, E.M. Kondaurova, D.V. Bazovkina, V.S. Naumenko, 2014, published in Molekulyarnaya Biologiya, 2014, Vol. 48, No. 6, pp. 983–989.
Rights and permissions
About this article
Cite this article
Tsybko, A.S., Il’chibaeva, T.V., Kondaurova, E.M. et al. Effect of central administration of the neurotrophic factors BDNF and GDNF on the functional activity and expression of 5-HT2A serotonin receptors in mice genetically predisposed to depressive-like behavior. Mol Biol 48, 864–869 (2014). https://doi.org/10.1134/S0026893314060181
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893314060181